Carlos A Gomez

12PUBLICATIONS
50CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)Cell physiologyGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 28, 2026
The Hidden Risk of Toxoplasmosis in the Expanding Immunomodulated Host Population: A Call for Guidelines and Registries in Patients on Biologics, Small Molecules, and Cellular Therapies.

|Nov 21, 2025
Prostatic Abscess due to Ureaplasma parvum in a Heart Transplant Recipient: Diagnostic Challenges and Clinical Utility of Metagenomics Next-Generation Sequencing (NGS).

Natalia E Castillo Almeida, Andre C Kalil, Carlos A Gomez

|Jul 14, 2025
Correction: How to approach a patient hospitalized for pneumonia who is not responding to treatment?

Pedro Povoa, Luís Coelho, Jordi Carratala

|May 24, 2025
How to approach a patient hospitalized for pneumonia who is not responding to treatment?

Pedro Povoa, Luís Coelho, Jordi Carratala

|Feb 21, 2025
Bridging the Gaps in CMV Management in Transplantation: Lessons From Resource-Limited Settings.

Carlos A Gomez, Andre C Kalil

|Jan 08, 2025
Baricitinib: The Immunomodulator of Choice for Severe COVID-19-The Verdict Is In.

Andre C Kalil, Carlos A Gomez

Pageof 2

Frequent Collaborators

5 joint publications

Andre C Kalil

3 joint publications

Daniel A Sweeney

2 joint publications

Pedro Povoa

2 joint publications

Michael Klompas